News
Getting to a Lifetime Genetic Textbook for Treating Disease
By Haim Neerman As a society, how much should be invested in creating a “transformative textbook of medicine, with insights…
Variantyx Licenses IBM Technologies That Leverage AI for Somatic Analysis
December 22, 2020 Variantyx, the leader in high complexity hereditary disease testing, today announced that it has entered into a…
Technology-Driven Precision Medicine Company Variantyx Secures $41.5M in Funding
Funding Round is Led by New Era Capital Partners and Includes Peregrine Ventures, Robert Bosch Venture Capital, 20/20 HealthCare Partners,…
Variantyx and Robert-Bosch Hospital team up to improve personalized oncology treatment
STUTTGART, Germany, Nov. 15, 2021 PRNewswire Robert Bosch Venture Capital GmbH, the corporate venture capital company of the Bosch Group, has…
Variantyx Expands Into Prenatal, Cancer Testing
May 11, 2021 Variantyx, a genetic testing company offering clinical whole-genome sequencing-based assays, is expanding its menu to include prenatal…